NCT04185415bepranemabprogressive supranuclear palsy
…inetics of bepranemab in participants with PSP.Methods PSP003 ( NCT04185415), a multicentre, double-blind, placebo-controlled, phase 1b stu…
1articles mentioning funders
1funder mentions
1distinct funders extracted
0%of mentions human-reviewed
Active filtersEntity: NCT04185415 ×
NCT04185415
This funder is selected. Its supporting articles are shown below.